Vitrolife Q3: Another quarter with improved organic CER growth - Redeye

Vitrolife continues to improve its organic growth, and the company has delivered two quarters with close-to-market growth. The reported Q3 sales are below expectations due to a higher FX headwind by 5%. Vitrolife is now on track to reinstalling a growth rate closer to its long-term target of >10%.

Länk till analysen i sin helhet: https://www.redeye.se/research/1045913/vitrolife-q3-another-quarter-with-improved-organic-cer-growth?utm_source=finwire&utm_medium=RSS